Koray Ayar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Koray Ayar has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Selime Ermurat
Department of Rheumatology, Bursa Yüksek İhtisas Training and Research Hospital, 16140 Bursa, Turkey
4 shared publications - Lale Altan
Department of Physical Medicine Rehabilitation and Rheumatology, Faculty of Medicine, Uludağ University, Bursa, Turkey
3 shared publications - Nizameddin Koca
Department of Internal Medicine, University of Health Sciences, Bursa Sehir Training & Research Hospital, Bursa, Turkey
3 shared publications - Tülay Dilara Hattatoğlu
Hacettepe University Faculty of Medicine
3 shared publications - Ali Asan
Department of Infectious Diseases and Clinical Microbiology, University of Health Sciences Bursa High Specialization Training and Research Hospital, Bursa, Türkiye
2 shared publications - Ayten Başak Karaakın Dinar
Department of Internal Medicine, Kestel State Hospital, Bursa, Turkey
2 shared publications
Latest Publications
- Open Access
- 30 September 2023
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 38 (3) , 375-386
Depression is the most significant independent predictor of fatigue in patients with primary Sjögren’s syndrome
Objectives: The study aimed to evaluate the level of fatigue and the relationship between mood, pain, fibromyalgia, insomnia, disease activity, and dryness with fatigue in primary Sjögren’s syndrome (PSS) patients. Patients and methods: In this case-control study, the participants were recruited between January 2021 and July 2021. Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F), pain DETECT questionnaire, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Insomnia Severity Index (ISI) were administered to 50 PSS patients (48 females, 2 males; mean age: 48.9±10.8 years; median age: 47 years; range, 29 to 71 years) and 60 healthy controls (HCs; 57 females, 3 males; mean age: 49.8±8.4 years, median age: 52 years; range, 32 to 72 years). In addition, EULAR Sjögren’s syndrome disease activity index (ESSPRI), EULAR Sjögren’s Syndrome Patient Reported Index (ESSDAI), pain thresholds, Schirmer tests, and whole unstimulated salivary flow rate measurements were determined in PSS patients. Independent predictors of fatigue (fatigue subscale scores
- 30 September 2023
- Published by AVES YAYINCILIK A.Ş. in Archives of Rheumatology
- Vol. 38 (3) , 375-386
Open AccessDepression is the most significant independent predictor of fatigue in patients with primary Sjögren’s syndrome
Objectives: The study aimed to evaluate the level of fatigue and the relationship between mood, pain, fibromyalgia, insomnia, disease activity, and dryness with fatigue in primary Sjögren’s syndrome (PSS) patients. Patients and methods: In this case-control study, the participants were recruited between January 2021 and July 2021. Functional Assessment of Chronic Illness Therapy Fatigue (FACIT-F), pain DETECT questionnaire, Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Insomnia Severity Index (ISI) were administered to 50 PSS patients (48 females, 2 males; mean age: 48.9±10.8 years; median age: 47 years; range, 29 to 71 years) and 60 healthy controls (HCs; 57 females, 3 males; mean age: 49.8±8.4 years, median age: 52 years; range, 32 to 72 years). In addition, EULAR Sjögren’s syndrome disease activity index (ESSPRI), EULAR Sjögren’s Syndrome Patient Reported Index (ESSDAI), pain thresholds, Schirmer tests, and whole unstimulated salivary flow rate measurements were determined in PSS patients. Independent predictors of fatigue (fatigue subscale scores
- Open Access
- 22 September 2022
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 49 (1) , 1-10
Fibroblast growth factor 23 (Fgf23) levels and their relationship with disease activity, bone mineral density, and radiological damage score in patients with rheumatoid arthritis: a single center case–control study
Background: There is limited and conflicting information on Fgf23 levels and their relationship with bone loss and disease activity in rheumatoid arthritis (RA). The aim of this study was to compare Fgf23 levels in RA patients with a healthy population and to evaluate the relationship between Fgf23 levels in RA with disease activity, bone mineral density (BMD), and radiological damage score. Results: The median Fgf23 levels in patients with RA and in hospital staff were 20.06 (11.2–51.0) and 26.40 (12.6–49.5) pg/ml (P < 0.001), respectively. RA patients were divided into active (DAS28 > 3.2) and inactive (DAS28 ≤ 3.2) subgroups. The median Fgf23 levels in active and inactive RA patients were 22.12 (13.90–51.02) and 17.71 (11.20–31.19) pg/ml, respectively (P = 0.001). BMD of RA patients was evaluated with dual-energy X-ray absorptiometry and radiological damage scores were evaluated independently by two investigators using the modified Sharp score (MSS). In RA patients, Fgf23 values correlated with DAS28 and with erosion score of observer-2 (r = 0.297, P = 0.036), but not with erosion score of observer-1 (r = 0.252, P = 0.077). No correlation was found between DAS28 and femur and lumbar vertebra BMD. Conclusion: In RA, Fgf23 is not associated with BMD but may be associated with local bone loss and disease activity.
- 22 September 2022
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 49 (1) , 1-10
Open AccessFibroblast growth factor 23 (Fgf23) levels and their relationship with disease activity, bone mineral density, and radiological damage score in patients with rheumatoid arthritis: a single center case–control study
Background: There is limited and conflicting information on Fgf23 levels and their relationship with bone loss and disease activity in rheumatoid arthritis (RA). The aim of this study was to compare Fgf23 levels in RA patients with a healthy population and to evaluate the relationship between Fgf23 levels in RA with disease activity, bone mineral density (BMD), and radiological damage score. Results: The median Fgf23 levels in patients with RA and in hospital staff were 20.06 (11.2–51.0) and 26.40 (12.6–49.5) pg/ml (P < 0.001), respectively. RA patients were divided into active (DAS28 > 3.2) and inactive (DAS28 ≤ 3.2) subgroups. The median Fgf23 levels in active and inactive RA patients were 22.12 (13.90–51.02) and 17.71 (11.20–31.19) pg/ml, respectively (P = 0.001). BMD of RA patients was evaluated with dual-energy X-ray absorptiometry and radiological damage scores were evaluated independently by two investigators using the modified Sharp score (MSS). In RA patients, Fgf23 values correlated with DAS28 and with erosion score of observer-2 (r = 0.297, P = 0.036), but not with erosion score of observer-1 (r = 0.252, P = 0.077). No correlation was found between DAS28 and femur and lumbar vertebra BMD. Conclusion: In RA, Fgf23 is not associated with BMD but may be associated with local bone loss and disease activity.
- 8 November 2021
- Published by Springer Nature in International Ophthalmology
- Vol. 42 (4) , 1147-1159
Evaluation of retinal microvascular structures by optical coherence tomography angiography in primary Sjögren’s syndrome
Objectives There are insufficient data in the literature on how retinal capillaries are affected in primary Sjögren's syndrome (PSS). The aim of this study was to evaluate the retinal capillary density (CD) in PSS using optical coherence tomography angiography (OCTA). Methods In this case–control study, 26 eyes from 13 PSS patients and 39 eyes from 20 healthy controls (HCs) were included. The CD in the regions of the superior capillary plexus (SCP), deep capillary plexus (DCP) and radial peripapillary capillaries (RPC) as well as assessment parameters of the foveal avascular zone (FAZ) were examined by OCTA. Results The mean CD (%) was 50.2 ± 4.2 and 50.5 ± 3.4 in the SCP (p = 0.904), 49.2 ± 7.5 and 53.9 ± 5.7 in the DCP (p = 0.006) and 50.8 ± 2.1 and 49.8 ± 2.2 in the RPC (p = 0.088) regions in patients with PSS and HCs, respectively. In patients with PSS and HCs, the mean sizes of the FAZ were 0.243 ± 0.07 mm2 and 0.283 ± 0.13 mm2 (p = 0.142), and the mean sizes of the non-flow area were 0.480 ± 0.11 mm2 and 0.509 ± 0.13 mm2, respectively (p = 0.359). The correlation coefficients (Rho) of retinal CD in the SCP, DCP and RPC regions with disease duration were − 0.545 (p = 0.004), − 0.389 (p = 0.050) and − 0.795 (p < 0.001), respectively. Conclusion The retinal CD in PSS is lower than that in the healthy population in deep retinal capillaries, and retinal CD shows a negative correlation with disease duration in PSS. Clinical trials registration This study was not registered to clinicaltrials.gov.
- 8 November 2021
- Published by Springer Nature in International Ophthalmology
- Vol. 42 (4) , 1147-1159
Evaluation of retinal microvascular structures by optical coherence tomography angiography in primary Sjögren’s syndrome
Objectives There are insufficient data in the literature on how retinal capillaries are affected in primary Sjögren's syndrome (PSS). The aim of this study was to evaluate the retinal capillary density (CD) in PSS using optical coherence tomography angiography (OCTA). Methods In this case–control study, 26 eyes from 13 PSS patients and 39 eyes from 20 healthy controls (HCs) were included. The CD in the regions of the superior capillary plexus (SCP), deep capillary plexus (DCP) and radial peripapillary capillaries (RPC) as well as assessment parameters of the foveal avascular zone (FAZ) were examined by OCTA. Results The mean CD (%) was 50.2 ± 4.2 and 50.5 ± 3.4 in the SCP (p = 0.904), 49.2 ± 7.5 and 53.9 ± 5.7 in the DCP (p = 0.006) and 50.8 ± 2.1 and 49.8 ± 2.2 in the RPC (p = 0.088) regions in patients with PSS and HCs, respectively. In patients with PSS and HCs, the mean sizes of the FAZ were 0.243 ± 0.07 mm2 and 0.283 ± 0.13 mm2 (p = 0.142), and the mean sizes of the non-flow area were 0.480 ± 0.11 mm2 and 0.509 ± 0.13 mm2, respectively (p = 0.359). The correlation coefficients (Rho) of retinal CD in the SCP, DCP and RPC regions with disease duration were − 0.545 (p = 0.004), − 0.389 (p = 0.050) and − 0.795 (p < 0.001), respectively. Conclusion The retinal CD in PSS is lower than that in the healthy population in deep retinal capillaries, and retinal CD shows a negative correlation with disease duration in PSS. Clinical trials registration This study was not registered to clinicaltrials.gov.
- Open Access
- 29 July 2021
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 3 (3) , 109-115
Prevalence of Hepatitis B virus serological groups in rheumatoid arthritis and association of previous hepatitis B virus infection with demographic data and parenteral therapies
Introduction: The aim of this study is to determine the frequency of Hepatitis b virus (HBV) serological groups in Rheumatoid arthritis (RA) and to compare the demographic characteristics and frequency of parenteral therapies between patient groups with and without previous HBV infection. Methods: Charts of RA patients were examined retrospectively. HBsAg, anti-HBc IgG, and anti-HBs test results were screened. All participants were divided into 3 serological groups (patients naive to HBV infection, previous HBV infection, vaccinated). Those with previous HBV infection were further divided into 3 serological subgroups (naturally immune, anti-HBc IgG positive only, chronic HBV infection). Findings were compared between RA patients with and without previous HBV infection. Results: Four hundred and fifty-one patients (female/male: 343/108) were included. The prevalence of patients naive to HBV infection, with previous HBV infection and vaccinated were 59.4%, 33.7%, and 6.9%, respectively. The prevalence of patients with naturally immune, anti-HBc IgG positive only, and chronic HBV infection were 25.7%, 4.4%, and 3.5%, respectively. Age in RA patients with and without previous HBV infection was 60.8±12.4 and 56.7±14.2 years, respectively(p
- 29 July 2021
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 3 (3) , 109-115
Open AccessPrevalence of Hepatitis B virus serological groups in rheumatoid arthritis and association of previous hepatitis B virus infection with demographic data and parenteral therapies
Introduction: The aim of this study is to determine the frequency of Hepatitis b virus (HBV) serological groups in Rheumatoid arthritis (RA) and to compare the demographic characteristics and frequency of parenteral therapies between patient groups with and without previous HBV infection. Methods: Charts of RA patients were examined retrospectively. HBsAg, anti-HBc IgG, and anti-HBs test results were screened. All participants were divided into 3 serological groups (patients naive to HBV infection, previous HBV infection, vaccinated). Those with previous HBV infection were further divided into 3 serological subgroups (naturally immune, anti-HBc IgG positive only, chronic HBV infection). Findings were compared between RA patients with and without previous HBV infection. Results: Four hundred and fifty-one patients (female/male: 343/108) were included. The prevalence of patients naive to HBV infection, with previous HBV infection and vaccinated were 59.4%, 33.7%, and 6.9%, respectively. The prevalence of patients with naturally immune, anti-HBc IgG positive only, and chronic HBV infection were 25.7%, 4.4%, and 3.5%, respectively. Age in RA patients with and without previous HBV infection was 60.8±12.4 and 56.7±14.2 years, respectively(p
- 1 April 2021
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 47 (1) , 35-42
Ailevi Akdeniz Ateşi Hastalığında Aksiyel Spondiloartrit Alt Grupları Arasında Klinik Bulguların ve Patojen Mutasyonların Karşılaştırılması
Bu çalışmada, Ailevi Akdeniz ateşi (FMF) hastalığı olan radyografik olan ve olmayan aksiyel spondiloartrit (aks-SpA) hastaları arasında, Akdeniz Ateşi (MEFV) gen mutasyonlarının ve FMF ilişkili klinik bulguların karşılaştırılması amaçlanmıştır. Çalışmada Ocak 2015-Temmuz 2020 tarihleri arasında FMF hastalığı tanısı ile takip edilmekte olan hastaların dosyaları retrospektif olarak incelendi. Hastaların genetik tetkikleri, klinik bulguları ve sakroilyak eklemin röntgen ve manyetik rezonans görüntüleme tetkikleri incelendi. Uluslararası Spondiloartrit Değerlendirme Birliği (ASAS) kriterlerine göre aks-SpA hastaları radyografik olan ve olmayan şeklinde gruplandırılarak çalışmaya dahil edildi ve bulgular gruplar arasında karşılaştırıldı. Aks-SpA tespit edilen toplam 36 hasta (24 radyografik, 12 radyografik olmayan) çalışmaya dahil edildi. Test sonuçlarına ulaşılabilen 11 aks-SpA hastasının hepsinde insan lökosit antijeni (HLA)B27 genetik test sonucu negatif bulundu. Radyografik olan ve olmayan aks-SpA hastaları arasında klinik bulgular, kolşisin yanıtı ve aile öyküsü farklı değildi. M694V mutasyonunun fenotipik frekansı radyografik olan ve olmayan aks-SpA grupları arasında sırasıyla, %91,7 ve %50,0 bulundu (p=0,005). V726A mutasyonunun fenotipik frekansı radyografik olan ve olmayan aks-SpA grupları arasında sırasıyla, %0 ve %25,0 bulundu (p=0,011). Sonuç olarak FMF’ye eşlik eden aks-SpA’nın alt grupları arasında FMF klinik bulguları farklı değildir. M694V mutasyonu röntgen bulgularının belirgin olduğu SpA alt grubunda, V726A mutasyonu da röntgen bulguları belirgin olmayan SpA alt grubunda daha sıktırlar ve bu mutasyonlar sık görüldükleri SpA alt gruplarının etyolojisinde rol oynuyor olabilirler.
- 1 April 2021
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 47 (1) , 35-42
Ailevi Akdeniz Ateşi Hastalığında Aksiyel Spondiloartrit Alt Grupları Arasında Klinik Bulguların ve Patojen Mutasyonların Karşılaştırılması
Bu çalışmada, Ailevi Akdeniz ateşi (FMF) hastalığı olan radyografik olan ve olmayan aksiyel spondiloartrit (aks-SpA) hastaları arasında, Akdeniz Ateşi (MEFV) gen mutasyonlarının ve FMF ilişkili klinik bulguların karşılaştırılması amaçlanmıştır. Çalışmada Ocak 2015-Temmuz 2020 tarihleri arasında FMF hastalığı tanısı ile takip edilmekte olan hastaların dosyaları retrospektif olarak incelendi. Hastaların genetik tetkikleri, klinik bulguları ve sakroilyak eklemin röntgen ve manyetik rezonans görüntüleme tetkikleri incelendi. Uluslararası Spondiloartrit Değerlendirme Birliği (ASAS) kriterlerine göre aks-SpA hastaları radyografik olan ve olmayan şeklinde gruplandırılarak çalışmaya dahil edildi ve bulgular gruplar arasında karşılaştırıldı. Aks-SpA tespit edilen toplam 36 hasta (24 radyografik, 12 radyografik olmayan) çalışmaya dahil edildi. Test sonuçlarına ulaşılabilen 11 aks-SpA hastasının hepsinde insan lökosit antijeni (HLA)B27 genetik test sonucu negatif bulundu. Radyografik olan ve olmayan aks-SpA hastaları arasında klinik bulgular, kolşisin yanıtı ve aile öyküsü farklı değildi. M694V mutasyonunun fenotipik frekansı radyografik olan ve olmayan aks-SpA grupları arasında sırasıyla, %91,7 ve %50,0 bulundu (p=0,005). V726A mutasyonunun fenotipik frekansı radyografik olan ve olmayan aks-SpA grupları arasında sırasıyla, %0 ve %25,0 bulundu (p=0,011). Sonuç olarak FMF’ye eşlik eden aks-SpA’nın alt grupları arasında FMF klinik bulguları farklı değildir. M694V mutasyonu röntgen bulgularının belirgin olduğu SpA alt grubunda, V726A mutasyonu da röntgen bulguları belirgin olmayan SpA alt grubunda daha sıktırlar ve bu mutasyonlar sık görüldükleri SpA alt gruplarının etyolojisinde rol oynuyor olabilirler.
- Open Access
- 7 March 2021
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 3 (Supplement) , 87-89
Recognizing the sarcoidosis behind the window of infection
Sarcoidosis is a chronic multisystemic inflammatory disease of unknown etiology, often associated with pulmonary involvement and characterized histopathologically by non-caseating granulomatous lesions. In this report, we aimed to present a 32-year-old patient who was hospitalized with a pre-diagnosis of cellulite, diagnosed with sarcoidosis based on skin lesions, and whose symptoms completely regressed with sarcoidosis treatment.
- 7 March 2021
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 3 (Supplement) , 87-89
Open AccessRecognizing the sarcoidosis behind the window of infection
Sarcoidosis is a chronic multisystemic inflammatory disease of unknown etiology, often associated with pulmonary involvement and characterized histopathologically by non-caseating granulomatous lesions. In this report, we aimed to present a 32-year-old patient who was hospitalized with a pre-diagnosis of cellulite, diagnosed with sarcoidosis based on skin lesions, and whose symptoms completely regressed with sarcoidosis treatment.
- Open Access
- 7 March 2021
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 3 (Supplement) , 29-30
Evaluation of Clinical, Genetic and Treatment-Related Characteristics in FMF Patients by Gender Distribution
The aim of this study is to investigate the differences between males and females in clinical findings, hereditary characteristics, treatment responses and pathogen Mediterranean fever (MEFV) gene phenotype frequencies in FMF patients. The data of 105 patients (70 females, 35 males) whose charts were available for all research data were evaluated. While evaluating the clinical findings; The age of attack onset, attack character, dominant attack location, presence of recurrent fever, appendectomy history and family history were evaluated. the response to colchicine treatment was questioned. The phenotype frequencies of the pathogen variations in the MEFV gene were determined. The frequency of individuals with typical attack character was 71.4% in women and 82.9% in men. The frequency of the predominant attack localization with peritoneum was 90% in women and 88.6% in men. The proportion of those with colchicine response was 92.8% and 85.7% in women and men, respectively. The phenotype frequencies of pathogen MEFV gene mutations were 62.7% and 88.6% for M694V (p=0.006), 22.4% and 14.3% (p=0.328) for V726A, 20.9% for M680I in women and men, respectively, and 22.9% (p = 0.819) and 14.9% and 14.3% (p=0.931) for E148Q. Clinical findings and treatment responses are not different in individuals with FMF disease. The frequency of the M694Vmutation, which has high penetration and is associated with important complications such as amyloidosis, is higher in men. There is a need for studies to evaluate FMF activity according to gender distribution.
- 7 March 2021
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 3 (Supplement) , 29-30
Open AccessEvaluation of Clinical, Genetic and Treatment-Related Characteristics in FMF Patients by Gender Distribution
The aim of this study is to investigate the differences between males and females in clinical findings, hereditary characteristics, treatment responses and pathogen Mediterranean fever (MEFV) gene phenotype frequencies in FMF patients. The data of 105 patients (70 females, 35 males) whose charts were available for all research data were evaluated. While evaluating the clinical findings; The age of attack onset, attack character, dominant attack location, presence of recurrent fever, appendectomy history and family history were evaluated. the response to colchicine treatment was questioned. The phenotype frequencies of the pathogen variations in the MEFV gene were determined. The frequency of individuals with typical attack character was 71.4% in women and 82.9% in men. The frequency of the predominant attack localization with peritoneum was 90% in women and 88.6% in men. The proportion of those with colchicine response was 92.8% and 85.7% in women and men, respectively. The phenotype frequencies of pathogen MEFV gene mutations were 62.7% and 88.6% for M694V (p=0.006), 22.4% and 14.3% (p=0.328) for V726A, 20.9% for M680I in women and men, respectively, and 22.9% (p = 0.819) and 14.9% and 14.3% (p=0.931) for E148Q. Clinical findings and treatment responses are not different in individuals with FMF disease. The frequency of the M694Vmutation, which has high penetration and is associated with important complications such as amyloidosis, is higher in men. There is a need for studies to evaluate FMF activity according to gender distribution.
- 1 December 2020
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 46 (3) , 291-297
Löfgren Sendromunda Kas-iskelet Sistemi Bulgularının Değerlendirildiği Klinik Araştırma
Biz bu çalışmada Löfgren sendromu ile takipli olan hastaların başlangıç eklem bulgularını ve seyrini, eklem bulgularına eşlik eden bulguları tespit etmeyi, kronik ve akut artrit ile seyreden olguların eklem ve laboratuvar bulguları ile kullandıkları ilaçları karşılaştırarak hangi değişkenlerin kronikleşmeyi etkilemiş olabileceğini araştırmayı amaçladık. Çalışmada 3071 hastanın dosyası retrospektif olarak incelenmiş olup 12 Löfgren sendromlu hasta çalışmaya dahil edilmiştir. Hastaların başlangıç klinik ve laboratuvar bulguları hasta dosyalarından, başlangıç görüntüleme tetkikleri "PACS" sisteminden, kas iskelet sistemi bulguları da telefonla veya yüz yüze görüşülerek elde edilmiştir. Katılımcılar akut artrit (
- 1 December 2020
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 46 (3) , 291-297
Löfgren Sendromunda Kas-iskelet Sistemi Bulgularının Değerlendirildiği Klinik Araştırma
Biz bu çalışmada Löfgren sendromu ile takipli olan hastaların başlangıç eklem bulgularını ve seyrini, eklem bulgularına eşlik eden bulguları tespit etmeyi, kronik ve akut artrit ile seyreden olguların eklem ve laboratuvar bulguları ile kullandıkları ilaçları karşılaştırarak hangi değişkenlerin kronikleşmeyi etkilemiş olabileceğini araştırmayı amaçladık. Çalışmada 3071 hastanın dosyası retrospektif olarak incelenmiş olup 12 Löfgren sendromlu hasta çalışmaya dahil edilmiştir. Hastaların başlangıç klinik ve laboratuvar bulguları hasta dosyalarından, başlangıç görüntüleme tetkikleri "PACS" sisteminden, kas iskelet sistemi bulguları da telefonla veya yüz yüze görüşülerek elde edilmiştir. Katılımcılar akut artrit (
- Open Access
- 3 November 2020
- Published by The European Research Journal in The European Research Journal
- Vol. 6 (6) , 631-639
Is fibromyalgia accompanying Behçet's disease more severe than primary fibromyalgia?
Objectives: Although there are studies in the literature about how Behçet's disease is affected in the presence of fibromyalgia, there is no information about how the severity of fibromyalgia is in the presence of Behçet's disease. This study aims to evaluate the severity of fibromyalgia by comparing the impact of fibromyalgia and pain thresholds between fibromyalgia patients with and without Behçet's disease. Methods: Twenty-five fibromyalgia patients with Behçet's disease and 34 primary fibromyalgia patients were included in this cross-sectional study. All participants completed the fibromyalgia impact questionnaire, and pain thresholds were measured at 18 tender points using algometry. Results: The mean fibromyalgia impact questionnaire scores in fibromyalgia patients with and without Behçet's disease were 66.6 ± 18.4 and 60.4 ± 14.5, respectively (p = 0.157). Pain thresholds were not different between the groups in 15 of the 18 tender points (TP). In fibromyalgia patients with Behçet's disease, pain thresholds in TP-15, TP-16 and TP-17 were 11.44 ± 4.84, 11.92 ± 5.00 and 15.16 ± 4.89 pounds, respectively, while in primary fibromyalgia patients those were 8.41 ± 2.68, 8.14 ± 2.76 and 12.14 ± 4.06 pounds respectively. Pain thresholds in TP-15, TP-16 and TP-17 were significantly different between the groups (p = 0.003, p = 0.003, p = 0.014, respectively). Conclusions: According to the literature data, although fibromyalgia has an effect on Behçet's disease, especially in cases associated with central sensitization syndromes, the severity of fibromyalgia was not found to be different in fibromyalgia patients with and without Behçet's disease in this study. There may be a relationship between Behçet's disease and fibromyalgia due to non-inflammatory causes such as central sensitization.
- 3 November 2020
- Published by The European Research Journal in The European Research Journal
- Vol. 6 (6) , 631-639
Open AccessIs fibromyalgia accompanying Behçet's disease more severe than primary fibromyalgia?
Objectives: Although there are studies in the literature about how Behçet's disease is affected in the presence of fibromyalgia, there is no information about how the severity of fibromyalgia is in the presence of Behçet's disease. This study aims to evaluate the severity of fibromyalgia by comparing the impact of fibromyalgia and pain thresholds between fibromyalgia patients with and without Behçet's disease. Methods: Twenty-five fibromyalgia patients with Behçet's disease and 34 primary fibromyalgia patients were included in this cross-sectional study. All participants completed the fibromyalgia impact questionnaire, and pain thresholds were measured at 18 tender points using algometry. Results: The mean fibromyalgia impact questionnaire scores in fibromyalgia patients with and without Behçet's disease were 66.6 ± 18.4 and 60.4 ± 14.5, respectively (p = 0.157). Pain thresholds were not different between the groups in 15 of the 18 tender points (TP). In fibromyalgia patients with Behçet's disease, pain thresholds in TP-15, TP-16 and TP-17 were 11.44 ± 4.84, 11.92 ± 5.00 and 15.16 ± 4.89 pounds, respectively, while in primary fibromyalgia patients those were 8.41 ± 2.68, 8.14 ± 2.76 and 12.14 ± 4.06 pounds respectively. Pain thresholds in TP-15, TP-16 and TP-17 were significantly different between the groups (p = 0.003, p = 0.003, p = 0.014, respectively). Conclusions: According to the literature data, although fibromyalgia has an effect on Behçet's disease, especially in cases associated with central sensitization syndromes, the severity of fibromyalgia was not found to be different in fibromyalgia patients with and without Behçet's disease in this study. There may be a relationship between Behçet's disease and fibromyalgia due to non-inflammatory causes such as central sensitization.